Item 2.02. Results of Operations and Financial Condition.
On November 4, 2021, SpringWorks Therapeutics, Inc. announced its financial
results for the quarter ended September 30, 2021. A copy of the press release
issued in connection with the announcement is being furnished as Exhibit 99.1 to
this Current Report on Form 8-K.
The information in this Current Report on Form 8-K (including Exhibit 99.1
attached hereto) is intended to be furnished and shall not be deemed "filed" for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
"Exchange Act") or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended or the Exchange Act, except as expressly set forth by
specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit               Description
No.

                        Press Release issued by SpringWorks Therapeutics, Inc. on     November     4,
99.1                  2021, furnished herewith.
104                   Cover page interactive data file (embedded within the

Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses